# Clinical trials recruiting in Georgia: 2,127 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 2,127 trials recruiting or not yet recruiting with a site in Georgia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Georgia: 2,127 rows for $101.27, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 42 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/georgia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 2,127
- Recruiting or not yet: 2,127
- Read on: November 19, 2026

## Trials

The 25 newest of 2,127, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946822 | Reducing Alcohol-Involved Suicidal Ideation and Behavior | Georgia State University | Not applicable | Not yet recruiting | Heavy Episodic Drinking, Suicidal Ideation and Behavior | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946822) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 16, 2026 | NCT07938567 | Preeclampsia Screening Trial to Improve Outcomes | Emory University | Not applicable | Not yet recruiting | Pregnancy Related, Hypertensive Disorder of Pregnancy (HDP) | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938567) |
| November 13, 2026 | NCT07935590 | Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical... | Aclaris Therapeutics, Inc. | Phase 2 | Recruiting | Lichen Planus | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935590) |
| November 13, 2026 | NCT07935317 | A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast Cancer | Eli Lilly and Company | Phase 2 | Not yet recruiting | Breast Neoplasms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935317) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 10, 2026 | NCT07927439 | Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic | Shepherd Center, Atlanta GA | Not applicable | Recruiting | Multiple Sclerosis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927439) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07909317 | Influence of Transcranial Electrical Stimulation on Arm and Hand Function After Cervical Spinal Cord Injury | Shepherd Center, Atlanta GA | Not applicable | Not yet recruiting | Spinal Cord Injury | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909317) |
| November 2, 2026 | NCT07909005 | Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant. | Swedish Orphan Biovitrum | Observational | Not yet recruiting | Hemophagocytic Lymphohistiocytosis (HLH), Macrophage Activation Syndrome (MAS), Still Disease | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909005) |
| October 30, 2026 | NCT07907991 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907991) |
| October 30, 2026 | NCT07907783 | Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia | Pelage Pharmaceuticals, Inc. | Phase 2 | Recruiting | Androgenetic Alopecia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907783) |
| October 30, 2026 | NCT07907562 | Ultrasound-Guided Electrical Dry Needling for Chronic Cervical Radiculopathy | Liberty University | Not applicable | Recruiting | Cervical Radiculopathy | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907562) |
| October 29, 2026 | NCT07905183 | A Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIs | Enliven Therapeutics | Phase 3 | Recruiting | Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic... | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905183) |
| October 29, 2026 | NCT07902817 | A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy | Jade Biosciences, Inc. | Phase 3 | Recruiting | IgA Nephropathy (IgAN) | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902817) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 27, 2026 | NCT07898917 | PureSee/Odyssey Mix-and-Match IOL | Gainesville Eye Associates | Observational | Not yet recruiting | Cataract | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898917) |
| October 26, 2026 | NCT07896070 | Impact of Higher Zinc Supplementation on Neonatal Weight Velocity | Augusta University | Phase 4 | Recruiting | Extreme Prematurity,Extremely Low Birthweight, BPD - Bronchopulmonary Dysplasia, Growth | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896070) |
| October 22, 2026 | NCT07890610 | Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest | Children's Hospital of Philadelphia | Observational | Recruiting | Cardiac Arrest (CA) | 1,620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890610) |
| October 21, 2026 | NCT07886268 | A Study to Evaluate the Efficacy and Safety of TP-06 for PCED | Tarsus Pharmaceuticals, Inc. | Phase 2 | Recruiting | Persistent Corneal Epithelial Defect | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886268) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Emory University | Atlanta | 218 |
| Emory University Hospital/Winship Cancer Institute | Atlanta | 126 |
| Emory University Hospital Midtown | Atlanta | 120 |
| Emory University Hospital | Atlanta | 96 |
| Emory Saint Joseph's Hospital | Atlanta | 80 |
| Children's Healthcare of Atlanta | Atlanta | 58 |
| Augusta University Medical Center | Augusta | 47 |
| Grady Health System | Atlanta | 46 |
| Northside Hospital | Atlanta | 43 |
| Emory University School of Medicine | Atlanta | 40 |
| Grady Memorial Hospital | Atlanta | 37 |
| Children's Healthcare of Atlanta - Arthur M Blank Hospital | Atlanta | 35 |
| Memorial Health University Medical Center | Savannah | 33 |
| Winship Cancer Institute, Emory University | Atlanta | 33 |
| Augusta University | Augusta | 30 |
| Winship Cancer Institute of Emory University | Atlanta | 29 |
| Emory Winship Cancer Institute | Atlanta | 29 |
| Emory Decatur Hospital | Decatur | 27 |
| Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Savannah | 25 |
| Atlanta VA Medical and Rehab Center, Decatur, GA | Decatur | 24 |
| Emory Johns Creek Hospital | Johns Creek | 23 |
| Piedmont Heart Institute | Atlanta | 23 |
| Piedmont Healthcare | Atlanta | 23 |
| Atlanta VA Medical Center | Atlanta | 23 |
| CenExel iResearch, LLC | Decatur | 21 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 11 |
| Phase 1 | 167 |
| Phase 1/2 | 106 |
| Phase 2 | 425 |
| Phase 2/3 | 64 |
| Phase 3 | 615 |
| Phase 4 | 78 |
| Not applicable | 405 |
| Observational | 256 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 82 |
| Neoplasms | 71 |
| Breast Neoplasms | 58 |
| Obesity | 57 |
| Multiple Myeloma | 53 |
| Prostatic Neoplasms | 47 |
| Lung Neoplasms | 44 |
| Overweight | 43 |
| Diabetes Mellitus, Type 2 | 42 |
| Leukemia, Myeloid, Acute | 42 |
| Colorectal Neoplasms | 40 |
| Neoplasm Metastasis | 39 |
| Depressive Disorder, Major | 33 |
| Ovarian Neoplasms | 33 |
| Schizophrenia | 31 |
| Alzheimer Disease | 31 |
| Cardiovascular Diseases | 29 |
| Recurrence | 29 |
| Depression | 29 |
| Endometrial Neoplasms | 28 |
| Triple Negative Breast Neoplasms | 27 |
| Heart Failure | 27 |
| Squamous Cell Carcinoma of Head and Neck | 26 |
| Pancreatic Neoplasms | 26 |
| Anemia, Sickle Cell | 25 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Emory University | 205 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 64 |
| National Cancer Institute (NCI) | 61 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 60 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 32 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 32 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 31 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 30 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 29 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 29 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 27 |
| Children's Oncology Group | 26 |
| VA Office of Research and Development | 24 |
| SWOG Cancer Research Network | 21 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 21 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 20 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 19 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 19 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 17 |
| NRG Oncology | 17 |
| Alliance for Clinical Trials in Oncology | 17 |
| Georgia State University | 15 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 15 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 14 |
| City of Hope Medical Center | 14 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Georgia

- [Mediators in Georgia, United States](https://specstream.ai/data/businesses/mediators/georgia-united-states)
- [Handyman services in Georgia, United States](https://specstream.ai/data/businesses/handyman-services/georgia-united-states)
- [Demolition contractors in Georgia, United States](https://specstream.ai/data/businesses/demolition-contractors/georgia-united-states)
- [Bathroom remodelers in Georgia, United States](https://specstream.ai/data/businesses/bathroom-remodelers/georgia-united-states)
- [Uniform stores in Georgia, United States](https://specstream.ai/data/businesses/uniform-stores/georgia-united-states)
- [Public relations firms in Georgia, United States](https://specstream.ai/data/businesses/public-relations-firms/georgia-united-states)
